APR-548

N/A

Report date: 2024/06/12 15:33:22
NME

Base Information

Drug NameAPR-548
Drug Alias NameAPR-548
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAprea Therapeutics Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAprea Therapeutics Ab
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A